(Q71025092)

English

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease

scientific article published on 01 January 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

author name string

D C Levin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K S Little

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K R Laughlin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J M Galbraith

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P M Gustman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D Murphy

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J A Kram

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

G Hardie

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

C Reuter

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D Ostransky

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K McFarland

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

T L Petty

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

W Silvers

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

S I Rennard

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M Mueller

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

L H Repsher

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R L Zuwallack

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R Vale

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

American Journal of Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

100

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1A

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

40S-48S

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Autonomic Regulation of the Airways

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Role of the parasympathetic system in airway obstruction due to emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Drug treatment of COPD. Controversies about agents and how to deliver them

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

The use of beta-agonists and the risk of death and near death from asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Ipratropium bromide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Standard and double dose ipratropium bromide and combined ipratropium bromide and inhaled metaproterenol in COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Bronchodilator responses to salbutamol followed by ipratropium bromide in partially reversible airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

A comparison of the effect of ipratropium and albuterol in the treatment of chronic obstructive airway disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Bronchodilator Responses to Anticholinergic and Beta-Adrenergic Agents in Acute and Stable COPD

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

A comparison of the effects of anticholinergic and beta 2-agonist and combination therapy on respiratory impedance in COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Bronchodilators in patients with chronic obstructive pulmonary disease on mechanical ventilation. Utilization of metered-dose inhalers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Measuring functional status in chronic lung disease: conclusions from a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Quality of life measurement for patients with diseases of the airways

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Effects of ipratropium bromide nebulizer solution with and without preservatives in the treatment of acute and stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

Comparison of ipratropium bromide and albuterol in chronic obstructive pulmonary disease: A three-center study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2980073-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9343(96)80073-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8610716%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71025092&oldid=2032818696"